Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defibrotide Prophylaxis in Sickle Cell Disease or Beta Thalassemia Following Stem Cell Transplantation
NCT02675959Phase 2Recruiting
- Sponsor
- New York Medical College
- Start
- Jul 2017
- Primary completion
- Dec 2026
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of defibrotide in sinusoidal obstruction syndrome (SOS), sponsored by New York Medical College. Started Jul 2017; status: recruiting.
02
Drugs
defibrotide
03
Conditions
sinusoidal obstruction syndrome (SOS)
Beyond the preview
Go deeper on NCT02675959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02675959.